EXAS - Exact Sciences Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
Madison,
United States
Type: Equity
EXAS price evolution
EXAS
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $582.74 | $530.18 | $347.49 | $605.38 |
| Short term investments | $416.6 | $304.61 | $172.27 | |
| Net receivables | $264.82 | $263.87 | $240.58 | $203.62 |
| Inventory | $136.99 | $127.37 | $128.53 | $127.47 |
| Total current assets | $1533.12 | $1452.49 | $1120.27 | $1194.37 |
| Long term investments | ||||
| Property, plant & equipment | $834.38 | $842.89 | $844.06 | $842.06 |
| Goodwill & intangible assets | $4210.45 | $4233.91 | $4257.52 | |
| Total noncurrent assets | $5220.81 | $5256.05 | $5276.97 | |
| Total investments | $416.6 | $304.61 | $172.27 | |
| Total assets | $6748.57 | $6673.3 | $6376.32 | $6471.33 |
| Current liabilities | ||||
| Accounts payable | $97.65 | $52.98 | $60.5 | $78.82 |
| Deferred revenue | ||||
| Short long term debt | $276.02 | $326.04 | $79.38 | |
| Total current liabilities | $723.66 | $668.64 | $685.11 | $514.7 |
| Long term debt | $2334.29 | $2485.61 | $2229.21 | $2475.35 |
| Total noncurrent liabilities | $2812.29 | $2558.59 | $2811.33 | |
| Total debt | $2761.63 | $2555.24 | $2554.72 | |
| Total liabilities | $3538.06 | $3480.93 | $3243.7 | $3326.03 |
| Shareholders' equity | ||||
| Retained earnings | -$3633.45 | -$3595.21 | -$3579.4 | -$3469.18 |
| Other shareholder equity | $1.8 | -$0.94 | -$0.5 | $1.43 |
| Total shareholder equity | $3192.36 | $3132.62 | $3145.3 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $605.38 | $178.17 | $315.47 | $1491.29 |
| Short term investments | $172.27 | $389.56 | $715 | $348.7 |
| Net receivables | $203.62 | $158.04 | $216.65 | $233.19 |
| Inventory | $127.47 | $118.26 | $104.99 | $92.27 |
| Total current assets | $1194.37 | $982.26 | $1426.24 | $2198.59 |
| Long term investments | $29.1 | |||
| Property, plant & equipment | $842.06 | $861.96 | $754.47 | $576.63 |
| Goodwill & intangible assets | $4257.52 | $4302.28 | $4429.58 | $2086.1 |
| Total noncurrent assets | $5276.97 | $5244.62 | $5258.65 | $2726.5 |
| Total investments | $172.27 | $389.56 | $715 | $348.7 |
| Total assets | $6471.33 | $6226.87 | $6684.88 | $4925.09 |
| Current liabilities | ||||
| Accounts payable | $78.82 | $74.92 | $67.83 | $35.71 |
| Deferred revenue | ||||
| Short long term debt | $79.38 | $28.37 | $19.71 | $268.27 |
| Total current liabilities | $514.7 | $412.75 | $517.07 | $575.84 |
| Long term debt | $2475.35 | $2243.51 | $2362.4 | $1464.18 |
| Total noncurrent liabilities | $2811.33 | $2770.96 | $2780.18 | $1525.76 |
| Total debt | $2554.72 | $2446.87 | $2382.11 | $1732.44 |
| Total liabilities | $3326.03 | $3183.71 | $3297.25 | $2101.6 |
| Shareholders' equity | ||||
| Retained earnings | -$3469.18 | -$3265.03 | -$2641.52 | -$1968.29 |
| Other shareholder equity | $1.43 | $0.05 | -$1.44 | $0.53 |
| Total shareholder equity | $3145.3 | $3043.16 | $3387.64 | $2823.49 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $699.26 | $637.52 | $646.88 | |
| Cost of revenue | $189.85 | $170.1 | $171.87 | |
| Gross Profit | $509.42 | $467.42 | $475.02 | |
| Operating activities | ||||
| Research & development | $120.88 | $110.61 | $114.92 | |
| Selling, general & administrative | $387.13 | $435.48 | $411.03 | |
| Total operating expenses | $535.67 | $574.12 | $542.86 | |
| Operating income | -$26.26 | -$106.69 | -$67.84 | |
| Income from continuing operations | ||||
| EBIT | -$14.46 | -$100.48 | -$42.51 | |
| Income tax expense | $1.46 | $1.81 | -$0.61 | |
| Interest expense | -$0.11 | $7.94 | $7.87 | |
| Net income | ||||
| Net income | -$15.81 | -$110.23 | -$49.77 | |
| Income (for common shares) | -$15.81 | -$110.23 | -$49.77 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2499.77 | $2084.28 | $1767.09 | $1491.39 |
| Cost of revenue | $654.25 | $574.39 | $458.76 | $354.32 |
| Gross Profit | $1845.52 | $1509.88 | $1308.33 | $1137.07 |
| Operating activities | ||||
| Research & development | $425.88 | $393.42 | $385.65 | $554.05 |
| Selling, general & administrative | $1620.29 | $1583.32 | $1663.15 | $1071.63 |
| Total operating expenses | $2060.53 | $2103.4 | $2164.01 | $1905.09 |
| Operating income | -$215.01 | -$593.51 | -$855.68 | -$768.02 |
| Income from continuing operations | ||||
| EBIT | -$182.3 | -$612.94 | -$823.9 | -$761.12 |
| Income tax expense | $2.4 | -$9.06 | -$246.88 | -$8.57 |
| Interest expense | $19.45 | $19.63 | $18.61 | $95.98 |
| Net income | ||||
| Net income | -$204.15 | -$623.51 | -$595.63 | -$848.53 |
| Income (for common shares) | -$204.15 | -$623.51 | -$595.63 | -$848.53 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$15.81 | -$110.23 | -$49.77 | |
| Operating activities | ||||
| Depreciation | $59.99 | $60.99 | $61.15 | |
| Business acquisitions & disposals | -$12.21 | |||
| Stock-based compensation | $56.55 | $60.37 | $58.58 | |
| Total cash flows from operations | $107.06 | -$82.31 | $69.55 | |
| Investing activities | ||||
| Capital expenditures | -$35.87 | -$37.65 | -$34.92 | |
| Investments | -$111.26 | -$133.58 | -$20.14 | |
| Total cash flows from investing | -$400.28 | -$147.13 | -$171.44 | -$66.77 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $19.45 | -$1.41 | $12.3 | |
| Net borrowings | $216.75 | |||
| Total cash flows from financing | $221.38 | $224.6 | -$3 | $10.04 |
| Effect of exchange rate | $0.43 | -$0.31 | -$1.14 | $1.95 |
| Change in cash and equivalents | -$15.01 | $184.23 | -$257.89 | $14.77 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$204.15 | -$623.51 | -$595.63 | -$848.53 |
| Operating activities | ||||
| Depreciation | $234.5 | $226.2 | $206.17 | $179.08 |
| Business acquisitions & disposals | -$52.91 | -$57.51 | -$575.85 | -$434.03 |
| Stock-based compensation | $231.31 | $206.82 | $334.02 | $152.91 |
| Total cash flows from operations | $156.12 | -$223.56 | -$102.24 | $136.48 |
| Investing activities | ||||
| Capital expenditures | -$124.19 | -$189.46 | -$135.77 | -$64.35 |
| Investments | $226.53 | $321.59 | -$369.73 | -$203.28 |
| Total cash flows from investing | $49.68 | $74.07 | -$1082.09 | -$702.04 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $31.54 | $32.02 | $37.51 | $907.13 |
| Net borrowings | $137.98 | $50 | -$23.75 | $975.49 |
| Total cash flows from financing | $159.77 | $76.48 | $8.47 | $1879.62 |
| Effect of exchange rate | $1.32 | $0.03 | $0.02 | |
| Change in cash and equivalents | $366.88 | -$72.98 | -$1175.83 | $1314.07 |
News
Fundamentals
| Market cap | $8.11B |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 185.05M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | 3.15 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.06 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.12 |
| Quick ratio | 1.93 |